Abstract

BackgroundUnderstanding the implementation of 2013 World Health Organization (WHO) consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection at the facility level provides important lessons for the roll-out of future HIV policies.MethodsA national policy review was conducted in six sub-Saharan African countries to map the inclusion of the 2013 WHO HIV treatment recommendations. Twenty indicators of policy adoption were selected to measure ART access (n = 12) and retention (n = 8). Two sequential cross-sectional surveys were conducted in facilities between 2013/2015 (round 1) and 2015/2016 (round 2) from ten health and demographic surveillance sites in Kenya, Malawi, South Africa, Tanzania, Uganda and Zimbabwe. Using standardised questionnaires, facility managers were interviewed. Descriptive analyses were used to assess the change in the proportion of facilities that implemented these policy indicators between rounds.ResultsAlthough, expansion of ART access was explicitly stated in all countries’ policies, most lacked policies that enhanced retention. Overall, 145 facilities were included in both rounds. The proportion of facilities that initiated ART at CD4 counts of 500 or less cells/μL increased between round 1 and 2 from 12 to 68%, and facilities initiating patients on 2013 WHO recommended ART regimen increased from 42 to 87%. There were no changes in the proportion of facilities reporting stock-outs of first-line ART in the past year (18 to 11%) nor in the provision of three-month supply of ART (43 to 38%). None of the facilities provided community-based ART delivery.ConclusionThe increase in ART initiation CD4 threshold in most countries, and substantial improvements made in the provision of WHO recommended first-line ART regimens demonstrates that rapid adoption of WHO recommendations is possible. However, improved logistics and resources and/or changes in policy are required to further minimise ART stock-outs and allow lay cadres to dispense ART in the community. Increased efforts are needed to offer longer durations between clinic visits, a strategy purported to improve retention. These changes will be important as countries move to implement the revised 2015 WHO guidelines to initiate all HIV positive people onto ART regardless of their immune status.

Highlights

  • Understanding the implementation of 2013 World Health Organization (WHO) consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection at the facility level provides important lessons for the roll-out of future HIV policies

  • Between December 2013 and May 2015, Kenya, Uganda, Tanzania, Malawi, Zimbabwe and South Africa revised their national antiretroviral therapy (ART) guidelines to make them consistent with the 2013 WHO guidelines on treatment eligibility [7]

  • We describe progress in the implementation of national policies on ART access and retention within the health facilities serving the populations of rural health and demographic surveillance sites (HDSS) in each country over the same time-period

Read more

Summary

Introduction

Understanding the implementation of 2013 World Health Organization (WHO) consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection at the facility level provides important lessons for the roll-out of future HIV policies. In 2015, 10.3 million people were receiving antiretroviral therapy (ART) in Eastern and Southern Africa compared with 4 million in 2010, accounting for 60% of the people receiving ART globally [1] This number is expected to increase further following revisions to the ART eligibility criteria in the 2015 World Health Organisation (WHO) guidelines that recommend treatment initiation for everyone who is HIV-infected, regardless of their immunological status (dubbed “universal test and treat”) [2]. Implementing these new guidelines will be an essential step towards achieving the UNAIDS “90–90-90” target (i.e. by 2020, 90% of HIV-infected people will be diagnosed, 90% of the individuals diagnosed will receive sustained ART and 90% of the individuals on ART will achieve viral suppression) in order to eliminate AIDS by 2030 [1]. The timeperiod between publication of the 2013 WHO guidelines on treatment eligibility (i.e. June 2013) and the revision of national ART guidelines averaged 12 months (range 6– 23 months)

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call